The methylation of CDH1, CDKN2Ap16, RASSF1A, TERT and WT1 were analyzed in 144 NSCLC and 7 healthy control tissue samples (a total of 151 patient samples), as summarized in Table 1. This evidence concerns the gene WT1 and non-small cell lung carcinoma.